ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
+0.150 (3.39%)
Feb 13, 2026, 4:08 PM HKT

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Out-Licensing Fee
77.35M
Collaboration Development
2.89M
Cell Strain and Other Products
120.35K
Cell Strain and Other Products Growth
-70.32%
Testing Services
30.36K
Testing Services Growth
44.60%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
China
80.39M
China Growth
18748.44%